APM
PACB icon

Avidity Partners Management’s Pacific Biosciences PACB Stock Holding History

Avidity Partners Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-675,000
Closed -$2.53M – 101
2024
Q1 		$2.53M Buy
+675,000
New +$3.95M 0.09% 85
2023
Q4 		– Sell
-1,034,294
Closed -$8.64M – 83
2023
Q3 		$8.64M Sell
1,034,294
-3,303,106
-76% -$37.7M 0.35% 67
2023
Q2 		$57.7M Buy
4,337,400
+524,800
+14% +$6.38M 2.01% 18
2023
Q1 		$44.1M Buy
+3,812,600
New +$37.9M 1.47% 27

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return